• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for metastatic uveal melanoma after trans-scleral local resection.经巩膜局部切除术后转移性葡萄膜黑色素瘤的危险因素。
Br J Ophthalmol. 1996 Feb;80(2):109-16. doi: 10.1136/bjo.80.2.109.
2
Uveal tumour resection.葡萄膜肿瘤切除术。
Br J Ophthalmol. 2001 Oct;85(10):1213-9. doi: 10.1136/bjo.85.10.1213.
3
Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.经巩膜局部切除术后葡萄膜黑色素瘤残留和复发的危险因素。
Br J Ophthalmol. 1996 Feb;80(2):102-8. doi: 10.1136/bjo.80.2.102.
4
Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma.脉络膜黑色素瘤分次立体定向放射治疗后二次眼球摘除相关的危险因素。
Acta Ophthalmol. 2015 Sep;93(6):555-60. doi: 10.1111/aos.12731. Epub 2015 Apr 15.
5
High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome.高剂量率和低剂量率钌近距离放射治疗葡萄膜黑色素瘤。与眼部结局无关。
Br J Ophthalmol. 2014 Oct;98(10):1349-54. doi: 10.1136/bjophthalmol-2014-305055. Epub 2014 May 13.
6
Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.脉络膜和睫状体黑色素瘤眼球摘除术后生存的预后因素。
Acta Ophthalmol Scand. 2004 Oct;82(5):517-25. doi: 10.1111/j.1600-0420.2004.00330.x.
7
Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up.后葡萄膜黑色素瘤眼球摘除术后的预后指标。对随访损失最小化的长期生存进行多变量分析。
Acta Ophthalmol Scand. 1995 Aug;73(4):340-4. doi: 10.1111/j.1600-0420.1995.tb00039.x.
8
Uveal melanoma: management and outcome of patients with extraocular spread.葡萄膜黑色素瘤:眼外扩散患者的管理与预后。
Br J Ophthalmol. 2010 May;94(5):569-74. doi: 10.1136/bjo.2009.165423. Epub 2009 Dec 3.
9
[Long-term prognosis of 29 patients with uveal malignant melanoma who were operated on by local resection or enucleation].[29例接受局部切除或眼球摘除手术的葡萄膜恶性黑色素瘤患者的长期预后]
Nippon Ganka Gakkai Zasshi. 2008 Oct;112(10):847-54.
10
Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.碘近距离放射治疗作为大型葡萄膜黑色素瘤眼球摘除术的替代方法。
Ophthalmology. 2003 Nov;110(11):2223-34. doi: 10.1016/S0161-6420(03)00661-4.

引用本文的文献

1
Surgical treatment of uveal melanoma: Exoresection versus endoresection.葡萄膜黑色素瘤的手术治疗:外切除与内切除
Taiwan J Ophthalmol. 2025 Feb 6;15(1):34-44. doi: 10.4103/tjo.TJO-D-24-00131. eCollection 2025 Jan-Mar.
2
Local Resection in Choroidal Melanoma: A Review.脉络膜黑色素瘤的局部切除术:综述
J Clin Med. 2022 Dec 1;11(23):7156. doi: 10.3390/jcm11237156.
3
Surgical Approach in Intraocular Tumors.眼内肿瘤的手术入路。
Turk J Ophthalmol. 2022 Apr 28;52(2):125-138. doi: 10.4274/tjo.galenos.2021.24376.
4
Surgical Resection of Intraocular Tumors (Partial Transscleral Sclerouvectomy Combined With Mircoinvasive Vitrectomy and Reconstruction of the Eyeball) in Asian Patients: Twenty-Five Years Results.亚洲患者眼内肿瘤的手术切除(部分经巩膜巩膜脉络膜切除术联合微创玻璃体切除术及眼球重建):25年结果
Front Oncol. 2022 Mar 15;12:768635. doi: 10.3389/fonc.2022.768635. eCollection 2022.
5
Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.新辅助质子束照射与辅助钌近距离放射治疗在葡萄膜黑色素瘤经巩膜切除术中的比较
Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1767-1775. doi: 10.1007/s00417-018-4032-7. Epub 2018 Jun 16.
6
Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.复发性虹膜黑色素瘤的挽救性质子束治疗:疗效与副作用
Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1325-1332. doi: 10.1007/s00417-018-3929-5. Epub 2018 Feb 20.
7
Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma.无降压麻醉下经巩膜切除术与碘-125 敷贴近距离放射疗法治疗脉络膜黑色素瘤的比较
Eye (Lond). 2016 Jun;30(6):833-42. doi: 10.1038/eye.2016.49. Epub 2016 Apr 1.
8
Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture.葡萄膜黑色素瘤患者管理的进展。2012 年阿什顿讲座。
Eye (Lond). 2012 Sep;26(9):1157-72. doi: 10.1038/eye.2012.126. Epub 2012 Jun 29.
9
Exoresection and endoresection for uveal melanoma.葡萄膜黑色素瘤的外切除与内切除
Middle East Afr J Ophthalmol. 2010 Jul;17(3):210-6. doi: 10.4103/0974-9233.65494.
10
Exoresection via partial lamellar sclerouvectomy approach for uveal tumors: A successful performance by a novice surgeon.经部分板层巩膜葡萄膜切除术治疗葡萄膜肿瘤的外切除术:一位新手外科医生的成功手术
Clin Ophthalmol. 2010 Feb 2;4:59-65. doi: 10.2147/opth.s8660.

本文引用的文献

1
Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.经巩膜局部切除术后葡萄膜黑色素瘤残留和复发的危险因素。
Br J Ophthalmol. 1996 Feb;80(2):102-8. doi: 10.1136/bjo.80.2.102.
2
Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial.氦离子与碘125近距离放射治疗在葡萄膜黑色素瘤治疗中的应用。一项前瞻性、随机、动态平衡试验。
Ophthalmology. 1993 Oct;100(10):1547-54. doi: 10.1016/s0161-6420(93)31446-6.
3
The prognostic value of tumor blood vessel morphology in primary uveal melanoma.肿瘤血管形态在原发性葡萄膜黑色素瘤中的预后价值。
Ophthalmology. 1993 Sep;100(9):1389-98. doi: 10.1016/s0161-6420(93)31470-3.
4
Predictive factors of visual outcome after local resection of choroidal melanoma.脉络膜黑色素瘤局部切除术后视力预后的预测因素
Br J Ophthalmol. 1993 Oct;77(10):616-23. doi: 10.1136/bjo.77.10.616.
5
Prognosis in uveal melanoma with extrascleral extension.
Arch Ophthalmol. 1980 Nov;98(11):1975-9. doi: 10.1001/archopht.1980.01020040827006.
6
Pattern of mortality in choroidal malignant melanoma.脉络膜恶性黑色素瘤的死亡率模式
Br J Ophthalmol. 1980 Aug;64(8):565-75. doi: 10.1136/bjo.64.8.565.
7
A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma.
Arch Ophthalmol. 1983 Dec;101(12):1894-9. doi: 10.1001/archopht.1983.01040020896012.
8
Ten years experience with eye wall resection for uveal malignant melanomas.
Ophthalmology. 1984 Dec;91(12):1720-5. doi: 10.1016/s0161-6420(84)34086-6.
9
Malignent melanomas of the human uvea. Recent follow-up of cases in Denmark, 1943-1952.人类葡萄膜恶性黑色素瘤。丹麦1943 - 1952年病例的近期随访
Acta Ophthalmol (Copenh). 1970;48(6):1113-28.
10
The local excision of choroidal melanomata.
Trans Ophthalmol Soc U K (1962). 1973;93(0):343-6.

经巩膜局部切除术后转移性葡萄膜黑色素瘤的危险因素。

Risk factors for metastatic uveal melanoma after trans-scleral local resection.

作者信息

Damato B E, Paul J, Foulds W S

机构信息

Tennent Institute of Ophthalmology, Western Infirmary, University of Glasgow.

出版信息

Br J Ophthalmol. 1996 Feb;80(2):109-16. doi: 10.1136/bjo.80.2.109.

DOI:10.1136/bjo.80.2.109
PMID:8814739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC505400/
Abstract

AIMS

This study reports the metastatic death rate after trans-scleral local resection of uveal melanoma and identifies relevant risk factors.

METHODS

Local resection was performed in 332 patients (mean age 51 years), with follow up ranging to 20.9 years (median for living patients 33 months). The tumours had a mean largest basal diameter of 13.1 mm and mean thickness of 7.5 mm, with 135 containing epithelioid cells. Risk factors were identified by Cox analysis and metastatic rates demonstrated using Kaplan-Meier curves.

RESULTS

There were 52 deaths from metastatic melanoma. The significant risk factors were (i) age more than 60 years at treatment (p = 0.001), (ii) mixed/epithelioid tumours (p = 0.003), (iii) superior location of mixed/epithelioid tumours (over and above (ii)) (p = 0.001), (iv) largest basal tumour diameter of 16 mm or more (p < 0.001), (v) lack of adjunctive radiotherapy (p = 0.031), (vi) secondary enucleation for bulky residual/recurrent tumour (p = 0.002), and (vii) secondary enucleation for small residual/recurrent tumour extraocularly (p = 0.019). Metastatic death was not significantly associated with (i) incomplete tumour excision (p = 0.163), and (ii) small residual/recurrent tumour treated by enucleation (p = 0.855).

CONCLUSIONS

Survival diminished from 92% at 15 years if less than two risk factors were present to less than 30% in 3.5 years if more than three risk factors were present.

摘要

目的

本研究报告了经巩膜局部切除葡萄膜黑色素瘤后的转移死亡率,并确定相关危险因素。

方法

对332例患者(平均年龄51岁)进行了局部切除,随访时间长达20.9年(存活患者的中位随访时间为33个月)。肿瘤的平均最大基底直径为13.1mm,平均厚度为7.5mm,其中135例含有上皮样细胞。通过Cox分析确定危险因素,并使用Kaplan-Meier曲线展示转移率。

结果

有52例因转移性黑色素瘤死亡。显著的危险因素为:(i)治疗时年龄超过60岁(p = 0.001);(ii)混合性/上皮样肿瘤(p = 0.003);(iii)混合性/上皮样肿瘤位于上方(在(ii)的基础上)(p = 0.001);(iv)最大基底肿瘤直径为16mm或更大(p < 0.001);(v)未进行辅助放疗(p = 0.031);(vi)因大块残留/复发性肿瘤而进行二次眼球摘除(p = 0.002);(vii)因眼外小残留/复发性肿瘤而进行二次眼球摘除(p = 0.019)。转移死亡与以下因素无显著关联:(i)肿瘤切除不完全(p = 0.163);(ii)通过眼球摘除治疗的小残留/复发性肿瘤(p = 0.855)。

结论

如果存在少于两个危险因素,15年生存率为92%;如果存在多于三个危险因素,3.5年生存率则降至30%以下。